Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 24, No 1 (January 1), 2006: pp. 123-128
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.03.5964

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chou, H.-H.
Right arrow Articles by Lai, C.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chou, H.-H.
Right arrow Articles by Lai, C.-H.

Low Value of [18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Primary Staging of Early-Stage Cervical Cancer Before Radical Hysterectomy

Hung-Hsueh Chou, Ting-Chang Chang, Tzu-Chen Yen, Koon-Kwan Ng, Swei Hsueh, Shih-Ya Ma, Chee-Jen Chang, Huei-Jean Huang, Angel Chao, Tzu-I Wu, Shih-Ming Jung, Yen-Ching Wu, Cheng-Tao Lin, Kuan-Gen Huang, Chyong-Huey Lai

From the Departments of Obstetrics and Gynecology, Nuclear Medicine, Radiology, Pathology, and Radiation Oncology, Chang Gung Memorial Hospital; and Graduate Institutes of Basic Medical Sciences and Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.

Address reprint requests to Chyong-Huey Lai, MD, Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital Linkou Medical Center, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan; e-mail: sh46erry{at}ms6.hinet.net

PURPOSE: The role of positron emission tomography (PET) with [18F]-fluoro-2-deoxy-D-glucose (FDG) in early-stage cervical cancer is unclear. We aimed to investigate the clinical benefit of FDG-PET in primary staging before radical hysterectomy and pelvic lymphadenectomy (RH-PLND).

PATIENTS AND METHODS: Patients with untreated stage IA2 to IIA adenocarcinoma (AD) or adenosquamous carcinoma (ASC) or nonbulky (≤ 4 cm) squamous cell carcinoma cervical cancer with magnetic resonance imaging (MRI) –defined negative nodal metastasis were enrolled onto a prospective study with a two-stage design. All patients had a preoperative dual-phase FDG-PET, technetium-99m–sulfur colloid lymphoscintigraphy, and intraoperative sentinel lymph node (LN) detection at RH-PLND. The gold standard of LN metastasis is histologic. A sample size of 120 patients was calculated to fit study aims (diagnostic efficacy of PET and sentinel LN sampling). An interim analysis was performed when 60 patients were accrued, which led to the current report.

RESULTS: There were 36 SCCs, 20 ADs, and four ASCs. Of the 60 patients, 10 (16.7%) had pelvic LN metastases, and one (1.7%) had para-aortic LN (PALN) metastasis histologically. FDG-PET detected the single PALN metastasis (one of one patient) but detected only one (10%) of the 10 pelvic LN metastases. The PET false-negative pelvic LN micrometastases measured a median of 4.0 x 3.0 mm (range, 0.5 x 0.5 to 7 x 6 mm). The second stage of this trial will be continued without PET.

CONCLUSION: This study shows that dual-phase FDG-PET has little value in primary, nonbulky, stage IA2 to IIA and MRI-defined, LN-negative cervical cancer.

Supported by Grants No. NSC-93-NU-7-182-003 from the National Science Council and the Institute of Nuclear Energy Research, Taiwan, and CMRPG32022 and CMRPG32029 from Chang Gung Memorial Hospital.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
A.-S. Bats, V. Lavoue, R. Rouzier, C. Coutant, K. Kerrou, and E. Darai
Limits of Day-Before Lymphoscintigraphy to Localize Sentinel Nodes in Women with Cervical Cancer
Ann. Surg. Oncol., August 1, 2008; 15(8): 2173 - 2179.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C.-H. Lai, C.-J. Chang, H.-J. Huang, S. Hsueh, A. Chao, J.-E. Yang, C.-T. Lin, S.-L. Huang, J.-H. Hong, H.-H. Chou, et al.
Role of Human Papillomavirus Genotype in Prognosis of Early-Stage Cervical Cancer Undergoing Primary Surgery
J. Clin. Oncol., August 20, 2007; 25(24): 3628 - 3634.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
H. H. Chung, S.-B. Kang, J. Y. Cho, J. W. Kim, N.-H. Park, Y.-S. Song, S. H. Kim, and H.-P. Lee
Can Preoperative MRI Accurately Evaluate Nodal and Parametrial Invasion in Early Stage Cervical Cancer?
Jpn. J. Clin. Oncol., June 7, 2007; (2007) hym036v1.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online